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Cancer is a genetic disease that involves the gradual accumulation of
mutations. Human tumours are genetically unstable. However, the current
knowledge about the origins and implications of genomic instability in
this disease is limited. Understanding the biology of cancer requires the
use of animal models. Here, we review relevant studies addressing the
implications of genomic instability in cancer by using the fruit fly, Drosophila
melanogaster, as a model system. We discuss how this invertebrate has helped
us to expand the current knowledge about the mechanisms involved in
genomic instability and how this hallmark of cancer influences disease
progression.1. Introduction
Genome integrity is constantly challenged by endogenous and exogenous fac-
tors that can induce a variety of DNA lesions leading to mutations and
damage in the chromosomes [1]. Each species needs to maintain the integrity
of the genome to guarantee a faithful transmission of its genetic content to
the next generation. To preserve the stability of genomes, different safeguard
mechanisms have been developed throughout evolution. Defects in these mech-
anisms can lead to the accumulation of mutations, which is known as genome
instability (GIN). The presence of GIN will ultimately affect gene expression
and the production and activity of numerous proteins, resulting in phenotypic
changes that can affect cellular fitness and trigger the development of diseases,
such as cancer [2].
Cell division, one of the most fundamental traits in biology, supports devel-
opment and growth, and is central to maintain homeostasis during the adult
life of multicellular organisms. Cells have to copy the DNA accurately to
ensure that both daughter cells acquire a complete set of the genome during
mitosis. Therefore, DNA replication during S-phase is a crucial point for the
maintenance of genome integrity. Aberrant replication fork progression leads
to replication stress and DNA damage [3]. Oncogene activation is a source of
replication stress [4–6]. This led to the oncogene-induced DNA damage
model that suffices to explain how an initiating mutation can trigger a cascade
of tumour-enabling factors. In this model, oncogenic activation can play a dual
role: on the one hand, it causes the expansion of tumorigenic cells through
higher proliferation signals, and on the other hand, it enables GIN through
replication stress [7]. In addition to replicative stress, other DNA-altering fac-
tors, such as ionizing radiation, can induce DNA damage and contribute to
the accumulation of mutations [8]. To combat the negative effects of DNA
damage, living organisms have evolved mechanisms, generally known as the
DNA damage response (DDR), to detect and repair these lesions. A defective
DDR results in an accumulation of mutations that can promote the initiation
and progression of diseases [9].
In a next step, dividing cells need to segregate their genetic content appro-
priately during mitosis to generate two daughter cells with a complete set of the
genome. Accurate chromosome segregation is hence crucial to ensure cell
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2viability and function. However, defects in this process
occasionally occur, and errors in mitosis are a source of struc-
tural and numerical chromosomal alterations commonly
observed in cancer cells [10]. Mitosis is a very dynamic pro-
cess. In the early stages, it involves the specification of two
distinct cell poles established by centrosomes; DNA conden-
sation into chromosomes and the formation of a mitotic
spindle. This is followed by the attachment of the chromo-
somes to the spindle, segregation of the chromatids and,
ultimately, the physical separation into two daughter cells
that takes place in cytokinesis. Due to its complexity, mitosis
has to be tightly coordinated. This is in large part controlled
by the spindle assembly checkpoint (SAC). This mechanism
monitors chromosome attachment to spindle microtubules
and avoids mis-segregation by preventing cells from starting
anaphase before the chromatids are connected to the spindle
[11]. A malfunction of this process can result in defects in
chromosome segregation known as chromosomal instability
(CIN). CIN is the most frequent type of GIN in human can-
cers and refers to the changes in chromosome number and/
or structure as a consequence of defects in mitosis. A primary
consequence of CIN is the formation of cells with unbalanced
chromosome content, a condition known as aneuploidy [12].
Abundant research into the mechanisms controlling the
stability of genomes has revealed central insights about
how defects in these processes cause genomic instability
and how it contributes to tumour initiation and progression.
However, we still lack a deeper understanding of the long-
term effects that this hallmark of cancer has in vivo. The use
of animal models that recapitulate the physiological conse-
quences and the impact that these errors have in disease is
crucial to elucidate the different links between GIN and
cancer. This review enumerates and discusses recent findings
addressing the connection between GIN and tumorigenesis
using the fruit fly, Drosophila melanogaster, as an in vivomodel.
Drosophila provides a tractable system with a sophisti-
cated genetic toolbox that has been used to model different
aspects related to human cancer [13]. It allows functional
analysis in vivo facilitatedby the accessibility to extensive collec-
tions of mutants and transgenic lines that can be used to
manipulate gene activity in different contexts. Additionally,
the flygenome sequence, aswell as transcriptomedataof differ-
ent tissues and life stages, is publicly available, which supports
genetic work. Flies have a short life cycle and can grow in big
numbers, and fly tumours develop quickly and progress from
primary tumours to malignancies in a short period of time.
These factors combine to allow one to produce tumour samples
on a large scale that can be used for high-throughput
approaches and facilitate the generation and quick validation
of hypotheses. Moreover, these tumours develop in vivo in an
immune-proficient situation, which permits interaction with
the microenvironment and with other cell types.
The first tumours in flies were identified over 100 years
ago [14]. Since then, the fruit fly has been a model system
used widely to study aspects of growth regulation and
tumour formation [13]. For example, the cooperative inter-
action between the oncogene Ras-V12 and mutants of the
polarity protein scribble is a well-established fly cancer model
that recapitulates many characteristics of human cancers,
including aggressive neoplastic and metastatic behaviour
[15,16]. Drosophila is broadly used to model different features
of GIN. Here, we present the most relevant findings obtained
using the fruit fly to study the connection between GIN andcancer and discuss the major advantages and limitations of
modelling GIN in Drosophila together with the translational
impact of these findings in human cancer.2. Mitotic errors and chromosome
instability
Flaws in mitosis are a major source of CIN that is observed in
approximately 90% of solid human tumours [17,18]. Errors
affecting mitosis include malfunctioning of the SAC, inefficient
cohesion between sister chromatids, defective attachment
between the microtubules and chromosomes, centrosome
amplification, and incorrect timing of centrosome separation
[19]. These defects typically result in aneuploidy. Flaws in
cytokinesis, the last step of mitosis, can also occur and cause
the formation of polyploid cells [20]. Below, we illustrate the
strategies followed to model specific errors in mitosis and
discuss the main conclusions obtained from these studies.
2.1. Chromosome instability in the imaginal discs
Faithful chromosome segregation is the ultimate goal
during mitosis. To accomplish this, the microtubules of
the mitotic spindle bind to the kinetochores—a specialized
structure in the centromeric region of the mitotic chromo-
somes. Before the chromosomes separate in anaphase, the
SAC monitors that the spindle is properly bound to the
two kinetochores. Once the kinetochores are attached to
the spindle, the SAC becomes inactive, which results in
the activation of the anaphase-promoting complex/cyclo-
some (APC/C). The activation of the APC/C causes the
loss of sister chromatid cohesion and transition to anaphase
that will be followed by chromosome segregation and, even-
tually, cytokinesis [11]. In Drosophila, SAC dysfunction
or disruption of spindle kinetochore binding causes
segregation errors and aneuploidy [21–26].
The wing imaginal discs of Drosophila are epithelial sac-
like structures present in the larva that, after metamorphosis,
will give rise to the thorax and wings of the adult. This organ,
formed by symmetrically dividing cells that proliferate
actively during larval development, has been used exten-
sively to model different aspects of tumorigenesis [27].
RNAi-mediated depletion of genes involved in the SAC
induces CIN and aneuploidy in this organ [23,24]. Aneu-
ploidy, a cell condition defined by an unbalanced number
of chromosomes, generally has a negative effect on cell fitness
[28–31]. Consistently, aneuploidy in the wing primordium
leads to cell delamination and apoptosis. In mammals, the
induction of apoptosis in response to CIN is p53-dependent
[32,33]. In flies, this response is p53-independent and relies
instead on the activation of the c-Jun N-terminal kinase
(JNK) pathway [23]. Aneuploidy in the wing disc, as in mam-
malian cells [34], causes the production of reactive oxygen
species (ROS), which contributes to the activation of the
JNK cascade [22]. Suppression of apoptosis in these cells is
sufficient to induce the formation of metastatic tumours
[23,24] (figure 1).
2.2. Chromosome instability in stem cells
The response to CIN in stem cells differs notably from the one
reported in symmetrically dividing cells of the imaginal
diploid cell
errors of the
mitotic machinery
chromosomal
instability
aneuploidy
JNK
cells resistant
to apoptosis
cells susceptible
to apoptosis
apoptosis tumorigenesis
mis-segregation
of chromosomes
Figure 1. Responses to chromosomal instability. Errors of the mitotic machin-
ery and its control mechanisms, such as the SAC, can trigger chromosomal
instability. Diploid cells, including epithelial cells and stem cells, can undergo
a mis-segregation of chromosomes, for example through multipolar mitosis.
This can lead to aneuploidy, which describes the divergence from a diploid
karyotype. In turn, the JNK stress signalling pathway is activated due to aneu-
ploidy. This stress signalling mediates the removal of the damaged cells
through apoptosis. For example, this is the case for wing imaginal epithelial
cells. However, a resistance to apoptosis of cells can lead to tumorigenesis.
This is the case for intestinal stem cells that generally do not undergo apop-
tosis. Epithelial cells that suppress apoptosis, for example through genetic
manipulation, trigger tumorigenesis as well.
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3primordia. The Drosophila midgut is an excellent system to
study adult stem cells in vivo. The maintenance and regener-
ation of the fly midgut and the mammalian intestine are
remarkably similar and rely on the activity of intestinal stem
cells (ISCs) [35–37]. Induction of CIN by SAC downregulation,
kinetochore malfunction or centrosome amplification leads to
the accumulation of aneuploid ISCs in the fly intestine. As
observed in the imaginal epithelium, aneuploid ISCs activate
the JNK pathway. However, in contrast to imaginal cells,
ISCs do not undergo apoptosis and, instead, overproliferate
causing the formation of tissue dysplasia [23,25]. ISCs are
resistant to apoptotic signalling, and this may be central
explaining the pro-tumorignic role of JNK in this specific cel-
lular context [25,38]. In agreement with this, cultured
mammalian embryonic stem cells tolerate aneuploidy and
polyploidy without undergoing apoptosis [39]. Failure toremove aneuploid cells in this context might increase the
levels of aneuploidy that could eventually drive tumorigenesis
(figure 1).
Tissue dysplasia as a consequence of CIN does not seem
to reflect a general behaviour in Drosophila stem cells. In the
larval brain, neural stem cells, or neuroblasts, divide asym-
metrically, and are essential for brain development and
homeostasis [40]. Neuroblasts have the potential to stem
tumour formation. For example, mutants disrupting asym-
metric cell division can develop brain tumours, and these
neoplasms, when injected in healthy hosts, continue growing
after multiple rounds of transplantation, show malignant
traits and kill eventually the host [41]. This allograft assay
has been extensively used to study the oncogenic potential
of different genetic conditions in flies. The analysis of
mutants for the SAC components bub3 and bubR1 in this
assay did not identify the formation of brain tumours,
which indicates that the cellular responses to the presence
of aneuploidies in stem cells varies depending on the cellular
context [42].
2.3. Cytokinesis failure and polyploidy
Cytokinesis, the last step of mitosis, mediates the physical
separation of the mother cell into two daughter cells. This
mechanism is complex, and defects in cytokinesis can lead
to the formation of polyploid cells [43]. These cells contain
extra centrosomes that can disrupt normal chromosome seg-
regation leading to the formation of aneuploid cells [44]. To
limit the threat posed by this, organisms have developed
tumour suppressor mechanisms. In mammals, cytokinesis
failure leads to the activation of the Hippo tumour suppres-
sor pathway, which represses the major transcriptional
mediator YAP and induces the stabilization of p53. Together,
these mechanisms induce G1 arrest and apoptosis [45].
We have recently developed a system to model cytokin-
esis failure and tumorigenesis in flies [46]. Septins play
central roles in cytokinesis by controlling the ingression of
the contractile ring [47]. Downregulation of the fly septin
peanut ( pnut) causes cytokinesis defects and tetraploidy. As
observed in other fly epithelial tissues with CIN, these cells
undergo apoptosis in a p53-independent and JNK-dependent
manner. However, suppression of apoptosis in cells with
cytokinesis failure is not sufficient to induce tumorigenesis,
as has been reported in epithelia with CIN induced by
other means [22–24]. Instead, cells with defective cytokinesis
proliferate poorly and accumulate in G2. Overexpression of
the proto-oncogene yorkie, the Drosophila homologue of mam-
malian YAP, is able to promote proliferation in these cells
causing the formation of tumours with high ploidy cells
and invasive behaviour. Functional experiments in this con-
dition show that Yorkie exerts its pro-tumorigenic role
through its target genes, the inhibitor of apoptosis DIAP1
and the G2/M regulator cdc25/string [46]. To reinforce this
response, Yorkie establishes a positive feedback through the
induction of the microRNA bantam, which consolidates
Yorkie activity by repressing head involution defective (hid), a
proapoptotic gene that induces cell death by targeting
DIAP1 and the cell cycle regulator tribbles (trbl), a pseudoki-
nase that dampens G2/M progression by inhibiting Cdc25/
string [48–55]. Hence, Yorkie suppresses apoptosis and
forces G2/M progression directly, by inducing the expression
of DIAP1 and cdc25/string respectively, and indirectly,
royalsocietypublishing.org/journal/rsob
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4through the microRNA bantam. MicroRNAs are proposed to
be embedded in gene networks that, in normal conditions,
could serve to manage biological noise and provide robust-
ness. However, in oncogenic situations, this may boost
tumorigenic programmes and promote disease progression
[56–58]. The conserved microRNA miR-8 also promotes
tumorigenesis in cooperation with the oncogene EGFR [59].
Cytokinesis failure is an early event in these tumours,
which occurs as a consequence of pnut repression by miR-8.
This, together with EGFR upregulation, leads to the for-
mation of giant tumour cells that use cell competition to
remove surrounding cells through cell engulfment and apop-
tosis [59,60]. A similar cooperation has been reported
between miR-8 and Yorkie [61].
Endoreplication can be used as an alternative to mitosis. It
involves a particular type of cell cycle where alternate rounds
of G–S result in the formation of large cells with a single poly-
ploid nucleus [62]. Endoreplication has been associated with
oncogenic transformation and tumour progression. However,
it is not well determined whether there is a causative associ-
ation between both processes [63]. A recent study in flies
sheds light on the implications of endoreplication in epithelial
tumours. Endocytic genes, including rab5, are well-recog-
nized tumour suppressors in Drosophila [64]. Cells depleting
rab5 activate JNK and Yorkie, which mediate a switch to
endoreplication causing the formation of polyploid cells.
JNK and Yorkie trigger this response by regulating the
death inhibitor DIAP1 and the G2/M regulator Cyclin B
[65]. Studies in flies have revealed that the inhibition of apop-
tosis and the induction of G2/M transition are crucial steps
towards tumorigenesis in the context of endoreplication and
cytokinesis failure [46,65]. Ultimately, the connection between
JNK activation, commonly observed in other tumours with
CIN, and the induction of endoreplication raise the question
whether other tumour types with CIN present a similar cell
cycle switch.
2.4. Centrosome amplification
Centrosomes are dynamic organelles that duplicate once per
cell cycle and function as the main microtubule organizing
centres during mitosis. Each centrosome comprises two
cylindrical structures known as centrioles. In early mitosis,
the kinase Polo becomes active and phosphorylates the scaf-
fold protein Centrosomin (CNN). As a consequence, CNN
assembles scaffold-like structures and recruits pericentriolar
material. Ultimately, γ-tubulin ring complexes are recruited
initiating the nucleation of the mitotic spindle. Abnormal
centrosomal dynamics can lead to defects in cell division
and aneuploidy, and consistently, different centrosomal
aberrations are common in human cancer [66].
Centrosome amplification is frequently observed in
human tumours and may correlate with poor patient progno-
sis [67]. However, it is debated whether centrosome
amplification is sufficient to cause tumorigenesis. The Sak
kinase (SAK) is involved in centriole biogenesis. SAK overex-
pression leads to supernumerary centrosomes, and this
genetic context has been used to study the effects of extra cen-
trosomes in flies. Flies upregulating SAK develop slowly yet
they are viable and fertile [68]. Symmetric dividing cells in
these animals initially form multipolar spindles but even-
tually become bipolar, leading to proper chromosome
segregation. In this context, mitosis progresses at a slowerrate, and this delay is mediated by the SAC, which provides
additional time for cells to cluster their centrosomes correctly
thus supporting the completion of error-free mitosis. In good
agreement, SAC depletion in symmetrically dividing cells
with extra centrosomes results in centrosome instability and
the formation of multipolar mitosis [68]. By contrast, the
induction of supernumerary centrosomes in neuroblasts
leads to abnormal mitosis. Asymmetric division in normal
neuroblasts produces a new neuroblast and smaller daughter
cells that will enter a differentiation path [69]. Intriguingly,
some neuroblasts with excessive centrosomes divide symme-
trically resulting in brains with an increase in the number of
stem cells. These brains develop tumours when injected in
healthy fly hosts [68]. Similarly, ectopic centrosomes in ISCs
trigger tissue dysplasia [25]. In summary, these studies
show that centrosome amplification can drive tumorigenesis
in fly stem cells. It is worth noting that, as observed when
modelling CIN in flies, cells with ectopic centrosomes trigger
different cellular responses in a cell type-dependent manner,
and the cellular outcomes of these defects are markedly
different between symmetric and asymmetric dividing cells.
Consistent with analyses performed in Drosophila, a recent
study shows that extra centrosomes can be an initiating event
of cancer in mammals [70]. Overexpression of the regulator of
centrosome duplication Polo-like kinase 4 (PLK4) leads to
supernumerary centrosomes and is a well-established tool
to induce centrosome amplification. Mammalian cells overex-
pressing PLK4 undergo cell cycle arrest in a p53-dependent
manner but, in p53-deficient mice, it accelerates tumorigen-
esis [71–73]. PLK4 was expressed in modest levels in mice
over eight months to address whether centrosome amplifica-
tion can be a single initiating factor. In this condition, chronic
centrosome amplification and aneuploidy is observed in
several tissues, including the skin, intestine and thymus, as
well as the spleen, and mice develop spontaneous tumours,
including carcinomas, lymphomas and sarcomas. Tumours
caused by chronic PLK4 activation show different karyo-
types and high heterogeneity of the tissue, which indicates
that tumours undergo continuous errors in chromosome
segregation. Notably, the p53 response seems to be generally
compromised in these tumours, providing further data sup-
porting that p53 limits the expansion of cells with ectopic
centrosomes in vivo [70].
Supernumerary centrosomes, independently of its conse-
quential impact in the generation of aneuploidy, can trigger
invasion [74]. Centrosome amplification can promote
changes in the cellular morphology, and epithelial cells over-
expressing PLK4 form dynamic protrusions, lose cell–cell
adhesion and invade surrounding tissues in organotypic cul-
ture. Mechanistically, centrosome amplification increases
microtubule nucleation that in turn increases Rac1 activity,
a central regulator of cell–cell adhesion and invasion
[74,75]. These results reveal an aneuploidy-independent
component of chromosomal amplification in cancer.
2.5. Acentrosomal cells
Even though centrosomes are the primary organizers of the
mitotic spindle in animal cells, centrosomes are not essential
for cell division in Drosophila. Flies that lack genes for centro-
some maintenance, such as Spindle assembly abnormal 4 (Sas-4)
and asterless (asl), develop into morphologically normal
adults [76,77]. Epithelial cells in Sas-4mutants use alternative
royalsocietypublishing.org/journal/rsob
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5non-centrosomal spindle assembly mechanisms, including
chromatin-mediated microtubule assembly and the SAC, to
segregate their chromosomes [78]. Although not essential,
centrosomes are required for effective spindle formation
and chromosome segregation in epithelial cells. Cells without
centrosomes present frequent defects in these processes that
lead to JNK-induced apoptosis. Centrosomes are also impor-
tant to orient symmetric cell divisions in the wing epithelium,
and defects in spindle alignment result in delamination and
apoptosis [78]. Interestingly, suppression of apoptosis in
cells with defects in the alignment of the spindle is sufficient
to trigger epithelial–mesenchymal transition (EMT) and
tumorigenic growth [79].
Allograft transplantation assays have been used to deter-
mine the tumorigenic potential of acentrosomal cells dividing
asymmetrically. Neuroblasts mutant for crucial components
of centrosome function, including Sas-4, polo and aurora A
(aurA), develop aneuploid tumours that show constant
growth when transplanted into adult flies and can be main-
tained after multiple allograft rounds [42]. Contrasting to
the wing epithelium, centrosome loss in the developing
brain does not activate the apoptotic response. In this context,
the SAC allows cells to survive and proliferate, and apoptosis
is only detected in brains that simultaneously lack centro-
somes and central SAC components, as observed in a Sas-4,
Mad2 double-mutant background. This genetic context dis-
rupts brain development severely resulting in reduced brain
size and lethality [80].
aurA encodes a protein kinase involved in neuroblast self-
renewal that functions as a tumour suppressor in Drosophila.
aurA mutant neuroblasts display cell fate mis-specification
and develop tumours [81,82]. Similarly, Sas-4 mutant neuro-
blasts show fate defects, and the resulting tumour
phenotype is comparable in both conditions. While the SAC
is required to sustain cell viability and proliferation in Sas-4
mutants, tumour growth is not affected when the SAC is inac-
tive in aurA brain tumours, where tumour cells complete
mitosis in a SAC-independent manner [81]. Cyclin B is a cen-
tral cell cycle regulator. The activation of the cyclin-
dependent kinase-1 (Cdk1) requires the binding of Cyclin B
to induce entry of mitosis, which finishes when Cyclin B is
degraded by the activity of the APC/C resulting in Cdk1
inactivation. The activated SAC inhibits the capability of
APC/C to ubiquitylate Cyclin B until metaphase [83]. In
aurA brain tumours, and contrary to Sas-4 mutants, Cyclin
B degradation is delayed leading to prolonged mitosis in a
SAC-independent manner, thus avoiding the deleterious
effect of SAC malfunction [81]. Therefore, the requirement
of the SAC differs in aurA and Sas-4 mutant genetic
backgrounds.
As observed in cells with defects in the SAC, centrosome
loss leads to the accumulation of ROS [22,84]. ROS is a well-
established activator of JNK signalling and may function as
an initiating factor of this stress response [85]. Several genes
involved in the redox balance are upregulated upon centro-
some loss [84]. In this context, glucose-6-phosphate
dehydrogenase (G6PD) has been identified as an enzyme
that buffers the increase of ROS and that protects cells against
cell death. G6PD generates NADPH that can be used to pro-
duce glutathione, which functions as a potent antioxidant
and hence limits the generation of ROS. The depletion of
G6PD in acentrosomal cells results in a robust increase in
apoptosis. Therefore, upregulation of G6PD in cells withoutcentrosomes dampens ROS limiting cellular damage and pre-
venting cell death [84]. In a context of defective SAC, cells
trigger the DDR, which buffers CIN-induced aneuploidy
and tumorigenesis, and p38, which is required to counteract
CIN-induced JNK activation [22] (figure 2a).
2.6. Cohesin complex errors
The cohesin protein complex has pleiotropic roles. It func-
tions as a molecular glue that holds sister chromatids
together after DNA replication. It is also involved in DNA
damage repair and plays important roles regulating gene
expression. The degradation of these proteins is required for
sister chromatid separation in anaphase, which is central for
proper chromosome segregation [86]. Given its importance
in mitosis, disruption of the cohesin complex can lead to
errors in chromosome segregation and aneuploidy. Based
on this principle, a genetic tool to induce aneuploidy in a
short time window has been developed in Drosophila [87].
The system is based on a modified version of the RAD21
cohesin subunit that contains Tobacco Etch Virus (TEV) pro-
tease cleavage sites [88]. Upon heat shock induction, the TEV
protease cuts RAD21 and causes a dysfunction of the cohesin
complex. The system is reversible and, immediately after
cohesin cleavage, expresses a TEV-resistant RAD21 protein
that restores cohesin activity. Live imaging shows that the
functionality of the cohesin complex is completely restored
within three rounds of mitosis after heat shock. Therefore,
this system allows acute and time-controlled induction of
aneuploidy by targeting cohesin [87].
Induction of aneuploidy during larval development by
cohesin manipulation is non-lethal, and animals develop
into adults. However, they show severe motor defects and
reduced lifespan due to the presence of aneuploid cells. The
induction of CIN leads to high levels of aneuploidy, where
up to 32 chromatids per cell can be observed, and causes neu-
roblast loss. Although decimated, the neuroblast population
is not completely eliminated, and the remaining stem cells
continue proliferating through development, which allows a
karyotype examination in these cells. Drosophila has only
two pairs of large chromosomes (chromosomes II and III),
one pair of minuscule autosomes (chromosome IV) and a
pair of sex chromosomes (X and Y) that are about half the
size of the large autosomes. A karyotype analysis shows
that loss of the major chromosomes (X, II and III) is not pre-
sent in these neuroblasts revealing the presence of karyotype
restriction, where loss of any of the main chromosomes is
incompatible with neuroblast proliferation. The induction of
aneuploidy by cohesin depletion in neuroblasts triggers a
delayed p53-dependent stress response that can only be
detected around 24–48 h after cohesin knockdown. This
reveals a delayed response that allows continuous neuroblast
proliferation and brain growth, despite the presence of gross
aneuploidies [87].3. Stress responses to aneuploidy
The most likely mechanism implicating CIN in tumorigenesis
is the generation of aneuploid cells, as a result of chromo-
some mis-segregation [70]. Although large-scale imbalances
are suggested to trigger excessive proliferation in Saccharo-
myces cerevisiae [89], aneuploidy impairs cell fitness and
DNA damage
response
JNK
JNK
p53
p38ROS
ATM/tefu ATR/mei-41
G6PD
Chk2 Chk1
cell cycle arrest
aneuploidy
gene dosage
imbalance
ER and proteo-
toxic stress
apoptosisapoptosis DNA repair
STOP
DNA damage
radiation(b)(a)
Figure 2. Stress responses to aneuploidy and radiation. (a) Aneuploidy triggers both gene dosage imbalances and ER as well as proteotoxic stress. This leads
together to oxidative stress and ROS accumulation. In turn, ROS can trigger JNK stress signalling. In parallel, cells activate p38 signalling, which can reduce
the activity levels of the JNK pathway. In acentrosomal cells, the accumulation of ROS leads to induction of G6PD. This mechanism may also be present in aneuploid
cells. It is likely that cells buffer JNK levels through p38 and potentially through G6PD to promote cytoprotective processes first, while higher levels of ROS and JNK
activate apoptosis. (b) Radiation can trigger DNA damage. This activates primarily the DDR through the ATM/tefu–Chk2 and ATR/mei-41–Chk1 signalling branches.
While both contribute to a genotoxic stress response through DNA repair, ATM/tefu–Chk2 mediates mostly p53-mediated apoptosis and can induce G2 cell cycle
arrest after low-dose irradiation. ATR/mei-41–Chk1 signalling triggers G2 cell cycle arrest after strong irradiation. Additionally, the JNK stress signalling pathway is
activated due to DNA damage. Both p53, which is activated through the DDR, and JNK mediate an apoptotic response in cells with high levels of DNA damage after
irradiation. Similar to stress responses to aneuploidy, the involved pathways likely buffer apoptotic signalling to determine whether cells undergo cell cycle arrest and
DNA repair or undergo cell death.
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6proliferation. Accordingly, aneuploidy has severe conse-
quences in animal growth as well as development, and
whole organism aneuploidy leads, in most cases, to early
lethality [28–31].
Cells with abnormal karyotypes present changes in gene
copy number that normally result in alterations in the cell
transcriptome and the proteome. This can disturb the
normal stoichiometry of protein complexes, hence disrupting
cellular functions [31]. Cells use different strategies to balance
the negative effect of aneuploidy. Studies in yeast and human
cells have revealed that aneuploid cells use protein aggrega-
tion mechanisms as an efficient strategy to dampen the
excess of subunits involved in protein complexes. This oper-
ates as a form of dosage compensation that allows cells to
cope with protein complex subunits present in abnormally
high proportions [90]. Human aneuploid cells also decrease
DNA and RNA metabolism, increase energy and membrane
metabolism, and upregulate autophagy as additional means
to counteract excessive protein accumulation [91]. Despite
the activity of those protecting mechanisms, aneuploidy ulti-
mately impairs cellular functions at different levels. In some
cases, it can even lead to a further increase in GIN accelerat-
ing the mutational rate and hence enhancing the detrimental
impact of aneuploidy [92–94]. The results showing that aneu-
ploidy reduces cellular fitness and impairs cell division seem
to conflict with the fact that aneuploidy is typically associatedwith cancer, which frequently involves uncontrolled cell pro-
liferation. The boost of GIN, a well-accepted hallmark of
cancer, observed in aneuploid cells can partially explain this
contradiction. GIN could facilitate the appearance of specific
mutations capable of driving cell adaptation, and ultimately
malignancy as well as cancer. Aneuploidy enables cellular
heterogeneity and fosters cell competition in tissues. This
can lead to a microevolution in the tissue and an expansion
of clones that can outcompete the surrounding cells [60].
Drosophila has been used as an in vivo platform to study
the consequences of CIN and aneuploidy on cellular fitness
and to determine the cellular responses produced to offset
these insults. A study based on the manipulation of the
sex-specific dosage compensation mechanism (DCM) has
recently shown that gene dose imbalance reproduces at
least part of the behaviour observed in aneuploid tissues
[22]. In Drosophila, where a single X chromosome defines
males and a set of two X chromosomes defines females, the
DCM ensures similar levels of expression in genes located
on the X chromosome in both sexes. To compensate this
imbalance, the male-specific lethal complex upregulates the
expression of genes on the X chromosome. The manipulation
of the DCM can be used to induce X chromosome-associated
gene dose imbalance. Given that the X chromosome constitu-
tes approximately a fifth of the fly genome, global changes in
the expression of this chromosome result in a wide gene dose
royalsocietypublishing.org/journal/rsob
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specific depletion of Msl2 leads to similar effects to the ones
observed when inducing CIN by knocking down elements
of the SAC, namely, ROS production, JNK activation as well
as apoptosis and tumour formation when cells are apopto-
sis-resistant [22,23]. The results presented in this study
suggest that gene dose imbalance suffices to explain, at
least in part, the deleterious effects that CIN has on cell fit-
ness and the pro-tumorigenic potential of aneuploid cells
[22] (figure 2a).
Other analyses in flies have shown that cells with CIN are
exposed to diverse kinds of stresses that sensitize cells to
additional insults [95,96]. For example, metabolic disruption
at levels well tolerated in normal cells leads to oxidative
stress, DNA damage and eventually apoptosis in cells with
CIN [96]. These cells also show chaperone upregulation, a
characteristic of the endoplasmic reticulum (ER) stress
response, and experience difficulties solving additional
stress induced by other proteins that have the tendency to
aggregate, as proteins with polyQ domains. Moreover, these
cells generate ROS and enzymatic disposal of hydrogen per-
oxide alleviates protein aggregation, indicating that the
proteotoxic stress response is intensified by the presence of
ROS. In addition to this, CIN also sensitizes cells to nucleo-
tide deprivation inducing additional DNA damage and
GIN [95]. These studies expose CIN-associated vulnerabilities
that could be exploited to design new therapeutic routes to
treat aneuploid tumours (figure 2a).
As observed in human cells, Drosophila epithelia with CIN
activate autophagy [91,97]. Lysosomal activity and autop-
hagy are crucial to cope with aneuploidy and ROS, and
inhibition of these processes results in increased apoptosis.
In this context, lysosomes are also required to buffer other
assaults, such as reduced nucleotide synthesis. As an
additional mechanism to counteract the accumulation of
ROS, aneuploid cells also use the secretory pathway to elim-
inate damaged mitochondria [95,97]. A recent report shows
that lymphoblastoid cells in human patients with Down syn-
drome, a disorder caused by trisomy on chromosome 21,
show increased hydrogen peroxide levels, chaperones and
higher expression of ER stress genes [98]. These results insin-
uate that the findings obtained in Drosophila, rather than
being insect-specific, could reflect a universal cell response
to aneuploidy.4. Chromosome instability and its
implications in invasion and metastasis
Comparative studies have shown that metastatic lesions
show higher levels of CIN than primary tumours [99].
This insinuates that CIN contributes to the evolution of
malignancy and suggests that CIN may be sufficient to pro-
mote invasive and metastatic behaviour. Studies in the wing
imaginal disc of Drosophila show that cells with CIN pro-
tected against apoptosis exhibit invasive traits [100]. These
cells emit actin protrusions and transition towards the
acquisition of mesenchymal-like morphology. The for-
mation of actin-enriched filopodia is triggered through
increased Myosin II and Drosophila Filamin—both actin
cross-linking proteins. The invasive behaviour relies on
JNK signalling, which increases Filamin protein, and the
EGFR pathway that stimulates invasiveness through theinduction of ERK and consequent repression of the
transcription factor Capicua [100].
The identification of cytosolic nucleic acids is a central
aspect in the recognition of pathogens by innate immunity.
This leads to the activation of sensor receptors, which in
turn mediate host defence mechanisms [101]. Chromosome
mis-segregation in cancer cells can lead to micronuclei as
well as cytosolic DNA and trigger inflammatory responses,
which is suppressed when CIN is inhibited [102]. Cytosolic
DNA activates the synthase cGAS and triggers the pro-
duction of cyclic guanosine monophosphate–adenosine
monophosphate (cGAMP), which binds the protein STING.
Consequently, the transcription factors IRF3 and NF-κB are
activated to mediate an inflammatory response [103,104].
While this cascade triggers interferon I production that med-
iates a host defence mechanism against viral and bacterial
infections, cancer cells are able to hijack this system for
their benefit. Ablation of STING in cancer cells leads to
reduced EMT gene expression and causes lower inflamma-
tory signalling. Conversely, providing cGAMP to cancer
cells with inhibited CIN results in an increased invasive be-
haviour and metastasis [105]. Together, this study indicates
that CIN and the resultant cytosolic DNA trigger immune
responses that benefit metastatic behaviour of cancer cells.
Notably, an inflammatory response after cytosolic DNA
recognition through STING is conserved in Drosophila [106].
STING binds cyclic dinucleotides and triggers an immune
response through the immune deficiency pathway that acti-
vates the NF-κB protein Relish, which induces the
expression of antimicrobial peptides. In agreement with
these results, the depletion of STING causes a higher suscep-
tibility to Listeria infections. Consistently, overexpression of
STING leads to Relish activation and the induction of antimi-
crobial peptides, which increases the resistance of flies to
pathogen infection [106]. This conserved mechanism may
be activated after CIN in Drosophila as well and could
resemble a mammalian response.5. DNA damage response
Cells are exposed to DNA-altering agents in their environ-
ment. Exogenous factors (such as UV light and ionizing
radiation in the sunlight), genotoxic agents (as for example
in cigarette smoke) or medical treatments can cause DNA
damage. Additionally, endogenous factors, including DNA
replication errors or ROS, can damage the DNA. To combat
these insults, cells have evolved DDR mechanisms aimed at
maintaining the DNA sequence and structure. However,
these processes are not flawless and DNA damage can gradu-
ally accumulate over the lifespan of an organism. In fact,
malfunction in the DDR is a main source of GIN that acceler-
ates the accumulation of mutations with obvious detrimental
effects for the organism [107].
The primary steps of the DDR are to detect the presence
and type of lesion in the DNA, halt the cell cycle when
needed and, depending on the kind of damage present, acti-
vate the necessary repair mechanism. When DNA damage is
overly strong, the DDR opts to induce senescence or apopto-
sis. Initially, the DNA damage is recognized by sensor
proteins. The kinases ATM and ATR, tefu and mei-41, respect-
ively in Drosophila, are two main mediators in DNA damage
sensing and repair [108]. Studies in mammals show that ATR
royalsocietypublishing.org/journal/rsob
Open
Biol.10:200060
8and ATM induce the DDR through the induction of Chk1 and
Chk2, respectively, which are the main mediators of the DDR
[109,110].
Cells use different mechanisms to fix lesions in their DNA.
Small base damages, including mismatching base pairs and
chemical changes of DNA bases, are repaired by the mis-
match and base excision repair. Larger lesions in the DNA
are fixed by the nucleotide excision repair. The single-strand
break repair fixes breaches of a single strand. The most threa-
tening lesions are double-strand brakes (DSBs), which are
recognized by phosphorylation of the H2AX histone through
ATM, and repaired during G2 through the error-free mechan-
ism called homologous recombination (HR) or during G1 by
the error-prone nonhomologous end joining (NHEJ) [109,111].
Oncogene-induced DNA damage is a central source of
GIN in cancer [7]. Human tumours frequently carry activating
mutations in the oncogene Ras [112], which induces premature
entry in S-phase and replicative stress that results in GIN.
Despite its prevalence in human cancer, drugs targeting this
oncogene in an efficient manner are starting to emerge only
recently [113,114]. Drosophila has been used to determine the
molecular mechanisms by which oncogenic Ras induces GIN
and to identify therapeutic and genetic strategies to selectively
eliminate Ras-driven tumours [115]. Oncogenic Ras induces
replicative stress and DNA damage. At the same time, it acti-
vates ERK that inhibits cell cycle arrest and p53-induced
apoptosis. Tumour cells activating Ras use ERK activity to sur-
vive and accumulate GIN, and consistently, genetic or
chemical repression of ERK, combined with ionizing radiation,
can efficiently eliminate Ras-induced tumours.
A recent analysis in Drosophila involves AurA in the DDR
[116]. aurA mutant neuroblasts, in addition of showing
chromosome aberrations, display inefficient DNA repair
and increased sensitivity to ionizing radiation. Genetic ana-
lyses in these mutants find that AurA regulates the DNA
ligase Lig4 negatively, which is involved in the final steps
of the NHEJ repair system. In the light of these results,
aurA mutants would present enhanced Lig4 activity contri-
buting to the appearance of chromosome aberrations.
Additionally, AurA cooperates with Rad51, an enzyme assist-
ing in the resolution of DSBs in post-replicative repair [116].
These results suggest that the negative impact that reduced
AurA activity has on genome integrity should be carefully
contemplated in therapies involving drugs used to target
this kinase.
5.1. Radiation and DNA damage response
Ionizing radiation-induced DNA damage is widely used to
study the DDR in Drosophila. Upon irradiation, different
responses have been described in flies. In first place, ATR/
mei-41 and ATM/tefu are triggered to activate their down-
stream targets Chk1 and Chk2, respectively. The ATR/mei-
41–Chk1 axis mediates, in large part, G2 arrest and can
induce mild p53 induction [117–119]. The ATM/tefu–Chk2
axis is mainly responsible for p53-dependent apoptosis
and can induce cell cycle arrest upon low-dose irradiation
[120–122]. Additionally, JNK activation triggers apoptosis in
a p53-independent manner [123] (figure 2b).
Irradiation of wing imaginal epithelial cells causes
tumorigenic growth when apoptosis is suppressed, and this
phenocopies the behaviour of cells with an impaired SAC
[23]. This tumorigenesis is triggered after irradiation byJNK stress signalling. Strikingly, the DDR functions as a
tumour suppressor mechanism in this condition. The study
indicates that HR DNA repair in G2 is crucial to suppress
tumour growth, while error-prone NHEJ DNA repair during
G1 has no effect on tumorigenesis. This gives particular rel-
evance to a G2 cell cycle arrest as part of the DDR. Indeed,
a G2 arrest is crucial to suppress tumour growth and the main-
tenance of this arrest, for example through the inhibition of the
G2/M regulator cdc25/string, and suppresses tumorigenic
growth substantially. Notably, the study indicates both ATR/
mei-41 and Chk1 buffer JNK activity in the tissue [124]. As
cdc25/string is suggested as an important target of JNK stress
signalling in tumour suppression [46], the DDR and JNK sig-
nalling may determine together whether a cell undergoes a G2
arrest to trigger HR DNA repair or is terminally damaged and
undergoes apoptosis (figure 2b).
A short ionizing radiation pulse is sufficient to cause
long-lasting JNK activity in fly epithelia [125]. When apopto-
sis is blocked in irradiated tissues, JNK induces the
production of ROS, which in turn reinforces JNK activation
and establishes an amplification loop that consolidates this
response. A direct consequence is the sustained expression
of JNK pro-proliferative targets, such as Wg, JAK-STAT and
Dpp, which all together stimulate robust tissue overgrowth
[125]. Furthermore, cells express the matrix metalloprotease
Mmp1 that degrades the basement membrane and enables
cells to invade other organs [124,126]. Given that HR is cru-
cial to repair lesions of the DNA, tissues that are irradiated
and prevented against apoptosis show stronger tumorigenic
traits when HR is non-functional [124].
Drosophila follicle cells have been used to study the DDR
in polyploid cells. During normal development, follicle cells
switch to endoreplication in a Notch-dependent manner.
After irradiation, the DDR is induced in these polyploid
cells. Notably, the downstream apoptotic response is blocked
in polyploid cells, and this leads to the accumulation of DNA
damage in the tissue [127,128]. These studies reveal a mech-
anism by which endoreplication and polyploidy may
contribute to GIN and tumorigenesis.6. Ageing
Cells replicate and repair their DNA numerous times during
the life of an organism. Polymerases copy the DNAwith high
fidelity, but it is estimated that they incorporate erroneous
nucleotides once per 108–1010 nucleotides polymerized
[129]. Furthermore, the DDR is not totally efficient. For
example, NHEJ is intrinsically inaccurate. Moreover, DNA
repair mechanisms are impaired with age, which causes an
age-related increase in the mutation rate [130–132]. Together,
these defects cause the continuous accumulation of altera-
tions in the DNA, which is considered a central molecular
driver of ageing [133]. An additional consequence is the pres-
ence of high levels of cell heterogeneity in aged tissues. This
can lead to competitive interactions between different cells,
hence facilitating the propagation of pre-malignant lesions
in early stages of tumour formation [60,107].
6.1. DNA damage response and lifespan
The observation that the DDR becomes compromised with
age, leading to a higher frequency of mutations, opens the
ageing
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Figure 3. Loss of chromosomal integrity and accumulation of mutations. (a) Ageing fly intestinal epithelia show frequent and spontaneous dysplastic growth arising
from the intestinal stem cell population (green). These stem cells show frequent large-scale rearrangements in their chromosomes with increased age. In particular,
the Notch locus, which is localized on the X chromosome, is frequently impaired and undergoes a loss heterozygosity leading to tumorigenic growth. Male flies in
particular show frequent dysplasia due to the presence of one X chromosome. (b) The oncogene-induced DNA damage model describes how an initial oncogene
activation can trigger broad DNA damage implications. In the first place, oncogenes, such as Ras or Cyclin E, can trigger DNA replication stress when the chromo-
somes are replicated during the cell cycle in S-phase. This can trigger DNA damages, and especially common fragile sites are susceptible to breaks and
rearrangements. Additionally, tumorigenesis triggers copy number variations and single-nucleotide polymorphisms. Together, these processes can lead to an erosion
of chromosomal integrity and broad changes to the encoded genetic information.
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9question whether upregulation of DDR genes may increase
lifespan. Genes involved in the DDR were overexpressed in
Drosophila to test this hypothesis, and the effect on lifespan
as well as stress resistance to different insults, such as
hyperthermia, oxidative stress and starvation, was analysed.
The genes tested included parts of the main DDR machinery,
base excision repair, nucleotide repair and DSB repair. The
obtained results regarding lifespan and stress resistance
varied between the different conditions analysed. Impor-
tantly, the expression of hus1 and chk2, which are involved
in the main DDR; mei-9 and mus210, which are part of the
nucleotide excision repair; and WRNexo, which plays a role
in DSB repair, are able to extend the lifespan and increase
stress resistance in the animals analysed. This provides evi-
dence supporting that upregulation of specific DDR
elements can have positive effects in ageing [134].
DNA repair defects are associated with syndromes that
present premature ageing, such as Werner syndrome. This
condition results from mutations in WRN, a gene encoding
for an essential enzyme involved in DNA repair [135]. The
analysis of WRN-deficient flies revealed that these animals
are sensitive to replicative stress, show shorter lifespan and
present increased tumour incidence [136]. This work provides
additional evidence substantiating the link between defective
DNA repair with premature ageing and cancer. Besides, it
provides a tractable in vivo model to study the molecular
basis of DNA damage-related ageing.6.2. Spontaneous tumorigenesis in ageing flies
Spontaneous tissue dysplasia has been observed in the
midgut of aged flies. The fly midgut is a well-organized epi-
thelium maintained by the activity of ISCs. During the ageing
process, the epithelium accumulates ISCs and shows mor-
phological irregularities. In the midgut, the JNK pathway
coordinates tissue regeneration by inducing proliferation in
ISCs. However, the effects of JNK activation in response to
stress vary in an age-dependent manner. While stress-
induced JNK drives ISC proliferation and regeneration in
young flies, JNK signalling in aged individuals results in
the accumulation of ISCs and defects in the epithelial archi-
tecture of the midgut [137]. Compared with young flies,
ISCs in aged individuals show regular loss of heterozygosity
caused by HR and frequent rearrangements that cause neo-
plastic growth. The majority of age-related neoplastic
lesions correlate with the presence of deletions and complex
rearrangements in the locus of the gene Notch [138]
(figure 3a).
The presence of invasive cancers in humans increases
from age 40 on [139]. Although this time exceeds significantly
the average lifespan of Drosophila, a comparative analysis
between ageing flies and mice revealed a higher frequency
of mutations in flies than in mice, suggesting that the
mutation rate is proportional to the biological, rather than
the chronological age [140,141]. This might provide an
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10explanation as why Drosophila can develop tumours during
its relatively short lifespan.
6.3. Drugs, tumours and healthy ageing
ISCs have been used as a model to study the effects of the
drug metformin in healthy ageing. Metformin is among the
most prescribed medications in developed countries. This
drug is used to treat type 2 diabetes and acts by reducing
insulin resistance and plasma insulin concentration, causing
a reduction in blood glucose levels. Metformin is also emer-
ging as a method for the prevention and treatment of
cancer [142]. ISCs in old flies are exposed to oxidative stress
and DNA damage, and aged flies can accumulate ISCs and
develop tumours [137,138,143,144]. Treatment with metfor-
min reduces ROS and DNA damage in ISCs, and this
inhibits the formation of hyperplasia in aged flies [145]. Con-
sistently with these results, metformin prolongs lifespan in
mice [146]. These studies provide additional evidence,
suggesting that reducing DNA damage can improve healthy
ageing.
Flies have been also used to interrogate the interactions
between metformin and other anticancer drugs. Doxorubicin
is used to treat cancer and acts by targeting and reducing the
activity of topoisomerase 2, which is required for tumour cell
proliferation. Despite its anti-tumoural effect, its use has
adverse consequences and induces cardiotoxicity presumably
due to the induction of ROS and DNA damage [147]. Exper-
iments in flies show that metformin alleviates the negative
effects of doxorubicin [148]. While doxorubicin on its own
induces DNA breaks and the formation of epithelial tumours
in Drosophila, the combined administration of doxorubicin
with metformin results in reduced DNA damage and
tumour incidence, demonstrating that metformin alleviates
the negative effect of doxorubicin in this experimental con-
dition [148]. The specific molecular function of metformin
in this context has not been determined and needs to be
investigated.7. Accumulation of mutations
GIN promotes the accumulation of different types of
mutations. However, the presence and pattern of mutations
in different tumour types do not occur entirely at random.
Some regions of the genome are more fragile and susceptible
to accumulate errors. Besides, specific factors can determine
the pattern of mutations present in different cancers. For
example, some tumours accumulate specific genomic changes
that vary depending on the initial oncogenic factors [149].
7.1. Chromosomal fragile sites
Chromosomal fragile sites are unstable loci that preferentially
show gaps and breaks in metaphasic chromosomes when
cells are exposed to replication stress. Over 120 individual
chromosomal fragile sites have been described in humans
[150]. They are subdivided into two categories: common
fragile sites (CFSs) and rare fragile sites (RFSs). RFSs occur
in few individuals—below 5% of the population—and
follow Mendelian inheritance. In most cases, an expansion
of repetitive nucleotide sequences is a central factor mediat-
ing the manifestation of RFSs. CFSs represent the majorityof fragile sites. They are well conserved trough evolution
and are molecular hotspots in cancer. CFSs are typically
late-replicating large genes with several exons that have a
reduced number of origins of replication. Moreover, they con-
tain relatively high AT-rich sequences that lead to the
formation of secondary structures. These features can
together predispose the DNA to the appearance of physical
collisions between the transcription and replication machi-
neries affecting the stability of these regions and eventually
causing chromosome breaks [151,152].
Fragile sites induce GIN and are associated with human
diseases, such as cancer. In vitro studies show that breaks at
CFSs occur after exposure to low doses of aphidicolin, an
inhibitor of DNA replication that induces replicative stress
[153]. DNA polymerase δ is a highly conserved enzymatic
complex that plays central roles in DNA replication and
repair in eukaryotes [154]. In its basic form, this complex
includes PolD, the catalytic subunit; Pol31, a structural sub-
unit; and Pol32, an auxiliary subunit [155]. A recent study
in Drosophila involves Pol32 in the generation of CFSs and
shows that, although Pol32 is crucial for genome replication
in early development, loss of Pol32 in later developmental
stages does not impede DNA replication and, instead,
induces the expression of CFSs [156] (figure 3b).
Oncogene activation can induce replicative stress and
specific fragile site landscapes that correlate to common
breakpoints in cancer [149]. Thus, oncogene activation can
facilitate GIN at fragile sites, which can potentially influence
other hallmarks of cancer. Chromosomal breaks at CFSs can
have oncogenic consequences. For instance, FRA3B and
FRA16D are CFSs that are located within tumour suppressor
gene loci. The tumour suppressor gene FITH is located at the
most active CFS, FRA3B, and is commonly dysregulated in
cancer. Similarly, the second most active CFS, FRA16D, is
situated within the WWOX gene [157]. In some cases, CFSs
can promote the amplification of oncogenes, such as MET
[158]. In summary, CFSs correlate with chromosome break-
points commonly found in cancer genomes [159,160]
(figure 3b).
WWOX is a long gene that resides in the FRAD16D
region, which is the second most common CFS in humans.
Loss of heterozygosity and homozygous deletions of
WWOX are commonly found in cancer [161]. WWOX is an
oxidoreductase involved in different cellular processes,
including cell metabolism, osteoblast differentiation and ster-
oidogenesis. Additionally, WWOX acts as a tumour
suppressor and affects DDR, p53 regulation and apoptosis.
WWOX is conserved from insects to mammals [162,163].
Drosophila Wwox shows a 49% similarity to the human
WWOX protein. Although WWOX null mutant mice show
severe metabolic defects and die in early development,
null fly mutants show no obvious phenotype [164,165].
Wwox mutant viability enabled an in vivo screen for Wwox-
interacting proteins. This screen identified 27 candidate
genes involved in aerobic metabolism. Genetic interactions
revealed functional connections with two proteins closely con-
nected with the tricarboxylic acid (TCA) cycle: isocitrate
dehydrogenase (Idh) and superoxide dismutase 1 (Sod1). In
Drosophila, knockdown of Idh leads to decreased viability,
which is enhanced by Wwox depletion. Reciprocally, Wwox
expression increases the viability of animals with reduced
Idh. The TCA cycle produces ROS. Sod1 is an enzyme convert-
ing superoxide to hydrogen peroxide playing a crucial role in
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mutants do not show viability defects on their own, trans-het-
erozygous mutants present reduced viability. Additional
experiments suggest that Sod1 regulates Wwox transcript
levels, both in Drosophila and HEK cells. Consistent with
these observations, Wwox has been shown to affect ROS
levels in Drosophila larvae [166].
Studies in mammalian models show that WWOX part-
ners with p53 to control cell death [167]. TNF-α is a central
regulator of apoptosis [168], and functional studies show
that Wwox cooperates with the TNF-α fly orthologue, Eiger
(Egr), in the regulation of the apoptotic response [169]. Egr
overexpression in the fly eye disrupts ommatidial mor-
phology and reduces overall eye size leading to a
characteristic ‘rough eye’ phenotype. Remarkably, Wwox
depletion rescues the Egr-induced ‘rough eye’ phenotype,
and Wwox overexpression enhances this defect. Mechanisti-
cally, Egr activates Wwox, leading to ROS release and ROS-
dependent apoptosis. Finally, Wwox has been shown to pro-
tect against ionizing radiation, suggesting an additional
mechanisms by which this gene could influence tumour
development [165]. In summary, studies in flies have served
to identify novel tumour suppressor roles of Wwox
[165,166,169].7.2. Copy number variations and single-nucleotide
polymorphisms
Cancer develops through the accumulation of mutations.
Ultimately, this can lead to aggressive, proliferative and meta-
static cells. GIN is thought to accelerate the acquisition of
mutations in tumour cells. Indeed, human cancer cells
accumulate genomic alterations faster than healthy cells
[170,171]. Although Drosophila larval neoplasms develop for
a short time period of around one or two weeks, tumour allo-
grafts into adult flies facilitate long-term analysis of fly
tumours. This approach has been used to address whether,
as observed in human cancer, Drosophila tumours accumulate
copy number variations (CNVs), understood as changes in
the number of copies of a given gene between different indi-
viduals; and single-nucleotide polymorphisms (SNPs), which
represent a difference in a single DNA nucleotide at a specific
position in the genome [172]. Several well-characterized brain
tumours types, such as l(3)mbt, brat, aurA or lgl, were
sequenced after the first, fifth and 10th round of transplan-
tation. Generally, the different tumours analysed remain
close to a diploid karyotype, indicating that aneuploidy is
not preferentially selected during tumour evolution in these
tumour types. Remarkably, these tumours show CNVs in
their genome. The number of CNVs varies between tumour
types, whereas l(3)mbt tumours show the lowest number
with 11 CNVs, brat tumours present 80 CNVs after the 10th
round of transplantation. In most of the cases, these alterations
affect coding regions, and the largest CNVs (above 500 kb) are
observed in late rounds of allografting [172] (figure 3b).
SNPs are present in all tested tumours. However, as
observed in human tumours, the frequency of SNPs varies
substantially between the Drosophila tumour types. While
brat tumours seem less susceptible to SNP accumulation,
aurA and lgl tumours present a dramatic eightfold increase
in the number of SNPs in late rounds of transplantation.
Interestingly, the number of SNPs per Mb is detected in acomparable range in the tested Drosophila tumours and
human cancer types. Ultimately, this study indicates that,
similar to human tumours, Drosophila tumours accumulate
CNVs and SNPs over time. Furthermore, the different
tumours analysed show diverse susceptibility to CNVs
and SNPs, which indicates that GIN varies in a tumour
type-dependent manner [172] (figure 3b).8. Conclusion
Aneuploidy has generally deleterious effects on growth and
development. However, most solid cancers show aneuploi-
dies and tumour progression correlates with GIN [173,174].
GIN increases genetic variability and cellular heterogeneity
contributing to natural selection during tumour evolution.
This selection process can favour the accumulation of specific
cancer-enabling mutations and facilitate drug resistance in
specific cell subclones [175]. In consonance with this, hetero-
geneous cell populations have been observed in cancer
tissues. A pan-cancer analysis addressing intratumour hetero-
geneity by determining clonal populations reveals that
tumours show on average four clonal subpopulations; 86%
of tumours contain at least two subpopulations; and the pres-
ence of two or more clones worsened the patient outcome
[176]. Although aneuploidy generally impairs cellular fitness,
it can be used to increase genetic variability, which can accel-
erate tumour progression by increasing cell adaptability and
by selecting highly competitive cancer cells [177].
The larval imaginal discs are commonly used to model
different aspects of tumour formation [27]. Despite its popu-
larity, this model has some obvious limitations in the study of
tumour evolution. Genetically induced tumours in Drosophila
larvae develop for approximately one to two weeks before
these animals die. This is a short time window for tumour
microevolution and expansion of different clonal subpopu-
lations, as observed in human cancers. Consistent with this,
analysis of structural variants in fly larval tumours driven
by depletion of the Drosophila tumour suppressor Polyho-
meotic does not show a loss of genome integrity [178,179].
Nevertheless, this system has proven valuable in investi-
gating the immediate- and short-term effects of GIN in
connection with tumorigenesis [22–24,46,124] (figure 4a).
Tumour transplantation in adult hosts emerges as an ideal
alternative to circumvent these limitations allowing to
explore the potential changes during tumour evolution pre-
sent in different genetic contexts [41,172]. This approach has
been used to examine CIN in neuroblasts, where cells show
a dramatic increase in polyploidy and aneuploidy after sev-
eral transplantation steps [42,68,81,82] (figure 4b). This
approach also reveals that fly neoplasms show GIN and
accumulate SNPs as well as CNVs that are in the range of
human cancers [172]. Additionally, ISCs have been helpful
in the study of stem cells and an analysis of ageing in adult
flies [25,138] (figure 4c).
The primary consequences of aneuploidy are changes in
gene copy number and gene dose imbalance. Changes in
copy number alter the expression of multiple genes that can
result in gain or loss of cancer genes, which would certainly
influence tumour progression. Additionally, chromosome
imbalance can trigger different cellular responses in the
form of activation or inhibition of certain pathways that
may contribute to tumour growth and malignancy. Flies
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Figure 4. Models to study the connection between genomic instability and tumorigenesis in flies. (a) The wing imaginal disc has been used extensively to model
aspects of genomic instability in epithelial cells. In this tissue, spindle assembly errors trigger tumorigenesis in apoptosis-deficient cells through the JNK signalling
axis. Similar to spindle assembly errors, ionizing radiation triggers neoplastic growth of epithelial cells that are apoptosis-deficient, and this tumorigenesis is
enhanced by the depletion of DDR genes. Cytokinesis failure triggers the JNK pathway as well, and an introduction of the oncogene Yorkie leads to tumorigenesis
that gives rise to highly polyploid cells. (b) Neuroblasts divide asymmetrically and the presence of centrosomes is essential for error-free mitosis in these cells. The
ablation or mis-localization of centrosomes as well as supernumerary centrosomes can lead to tumorigenic neuroblasts. Transplantations of neuroblasts with cen-
trosome defects form tumours in the abdomen of adult flies. (c) ISCs trigger dysplastic growth after spindle errors occur and behave similar to apoptosis-deficient
epithelial cells. Similarly, ageing flies trigger frequently dysplasia originating from ISCs, and this is due to age-related somatic mutations.
royalsocietypublishing.org/journal/rsob
Open
Biol.10:200060
12have their genome packed in only three major pairs of
homologous chromosomes. This contrasts with humans,
where the genome is distributed in 23 pairs of chromosomes.
Segregation mistakes in any of the main chromosomes of the
fly will affect a vast portion of the genome, limiting the use
of this model system to study the consequences of gaining
and/or losing specific genes present in particular chromo-
somes. Although this could be viewed as a limitation, it
allows to study the general consequences of aneuploidy,
independently of the specific genes affected by segregation
errors. Drosophila therefore provides a potent system to deter-
mine the cellular responses and consequences of gene dose
imbalance in aneuploid cells.
Studies in flies agree that the JNK pathway constitutes a
central response to CIN and mediates key cellular responses,
such as apoptosis, proliferation and transformation. Specifi-
cally, depletion of SAC components, the presence of
acentrosomal cells and cytokinesis defects induce JNK-dependent apoptosis in Drosophila epithelial cells [23,46,78].
JNK also controls the cell cycle, as observed in cells with
defective cytokinesis where JNK inhibits Cdc25/string, and
therefore limits G2/M progression [46]. Cdc25/string regu-
lation by JNK has also been reported to operate during
wound healing [180]. This regulatory interaction may be con-
served and has also been reported in human cells where JNK
regulates entry in mitosis by regulating CDC25C [181]. More-
over, JNK inhibits Cyclin B, another central G2/M regulator,
in Drosophila endoreplicating cells [65]. Furthermore, JNK
controls the acquisition of mesenchymal-like characteristics
and tumour invasion [100]. Even though JNK plays a central
role in response to GIN, the functions played by this signal-
ling pathway appear to be very complex and, while in
some contexts it limits tumour progression, in others it
behaves as a pro-tumorigenic factor [85,182,183].
The tumour suppressor gene p53 plays a central role in
preserving genome integrity. In the presence of different
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13forms of cellular stress, such as oncogene activation or DNA
damage, p53 controls diverse cellular responses to maintain
tissue homeostasis. The function of p53 in response to GIN
is notably different between flies and mammals. While in
mammals p53 induces cell cycle arrest and apoptosis in
response to stress stimuli, in flies its function is predomi-
nantly limited to the induction of the apoptotic response
[184–186]. Additionally, p53 limits the expansion of tetraploid
and aneuploid cells after cytokinesis failure and induces
apoptosis in these conditions [34,45,187,188]. While p53 is
activated by some forms of GIN in flies, the generation of
aneuploid cells by manipulation of the SAC or by cytokinesis
failure leads to p53-independent and JNK-dependent cell
elimination through apoptosis [23,46].
The severity of GIN influences cell behaviour differently
and, while moderate GIN can promote mutability and tumor-
igenesis, strong GIN can be incompatible with cell viability.
Supporting this notion, results in mice show that, although
weak SAC inhibition is oncogenic, severe SAC disruption
increases cell death and suppresses tumour formation [189].
Similar outcomes are observed in cultured glioblastoma
cells. These cells have segregation defects, show aneuploid
karyotypes and form tumours when injected in mice.
Additional induction of CIN through the expression of amicrotubule-depolymerizing kinesin, which leads to lower
error correction during chromosome segregation, causes
tumour suppression, and tumours were not formed when
these cells were injected in mice [190]. Consistently, a pan-
cancer analysis assessing CNVs shows that, while CNVs
affecting less than 25% or more than 75% of the genome is
beneficial for patient survival, intermediate CNV levels
result in a worse patient outcome [176]. These studies point
towards a novel therapy based on the induction of additional
GIN to induce lethality and suppress disease progression
[191]. These observations are relevant for fly tumour
models where different strategies to manipulate gene activity,
such as hypomorphic mutants, null alleles or RNAi-mediated
gene knockdown, may result in different cellular outcomes.Data accessibility. This article has no additional data.
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